학술논문
An exosome-based ESR1 monitoring RT-qPCR technology that rapidly and accurately detects circulating tumor acquired resistance variants at <= 0.1% frequency in liquid biopsy samples
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445